Search for: "Johnson v. Johnson Publishing Co" Results 361 - 380 of 511
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Mar 2018, 6:09 pm by Wolfgang Demino
JUSTICE BLACKLOCK did not participate in the decision.PHIL JOHNSON, Justice.This case involves an arbitration provision in short-term loan contracts. [read post]
12 May 2010, 1:04 pm by Berin Szoka
My dear friend, fellow space/IT/priavcy/communications lawyer and now PFF Adjunct Fellow Jim Dunstan just published this PFF paper, which I thought I’d share with you (PDF) ______________________ The FCC’s Title II “Lite” (as a Lead Balloon!) [read post]
23 May 2008, 1:03 am
: (IPBiz) Global - Copyright Musopen puts classical recordings, scores in public domain: (Ars Technica) Events 26-27 May : EU Workshop for mediators in IP disputes – Geneva: (IPR-Helpdesk), 27 May: Oliver Rivers to give short talk on ‘spurious precision’ – London: (IP finance), 28 May / 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – New York / San Francisco: (Patent Docs),… [read post]
12 Feb 2021, 11:17 am by Eric Goldman
Twitter would still permit brands and celebrities to publish (and maybe Eugene, but not me). [read post]
20 Sep 2022, 7:56 am by Phil Dixon
This post summarizes criminal and related decisions published by the Fourth Circuit Court of Appeals during August 2022. [read post]
13 Jun 2008, 3:40 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v Hutchinson 3G UK Limited: (Out-Law), (Catch Us If You Can!!!) [read post]
4 Nov 2016, 4:39 am by Edith Roberts
City of Miami and Wells Fargo & Co. v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
3 May 2014, 8:56 am by Schachtman
This evidence is derived from correctly interpreted papers that have been published in the peer-reviewed literature. [read post]